Clinical Trial Update: Liposomal Bupivacaine vs Peripheral Nerve Block [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing liposomal bupivacaine to peripheral nerve block was terminated; results were posted in 2023. No detailed efficacy or safety conclusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Opioid Use
• Pain Acute
• Surgery

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Geisinger Clinic | Conditions: Pain, Acute, Surgery | Phase 4 | Status: TERMINATED | Results posted: 2023-02-23